BC Extra | Jan 17, 2019
Preclinical News

NIH to bring iPS cell therapy into clinic for dry macular degeneration

Researchers at NIH's National Eye Institute (NEI) developed clinical-grade protocols for producing an autologous induced pluripotent stem cell-derived therapy for dry age-related macular degeneration. NEI plans to use the methods, reported in a Science Translational...
BC Week In Review | Jun 8, 2018
Clinical News

Osaka University starts trial of iPS cell-derived cardiomyocyte sheets

Researchers at Osaka University (Osaka, Japan) started a clinical trial evaluating an induced pluripotent stem (iPS) cell-based therapy to treat severe ischemic cardiomyopathy. The trial will assess safety and change in cardiac function. The therapy...
Items per page:
1 - 2 of 2